• Medical Adhesives Formulation: Strategies for Biocompatibility, Sterilization Stability, and Clinical Performance

    Advanced training on medical adhesive formulation covering biocompatibility, ISO 10993 strategy, sterilization stability, and clinical performance control.

6 Month Access

Get full access to the complete training and stay connected to the training ecosystem for 6 months.

Training Certificate

Validate your expertise with a verifiable credential that employers trust and recognize.

Training Materials

Download presentation slides, expert-prepared FAQs, Q&A, practical toolkits and more.

Expert Connect

Connect with the expert 24/7 via the discussion forum to clarify your technical questions.

Adhesives and sealants used in the medical industry must perform reliably while being safe for direct or indirect contact with the human body. Unlike industrial systems, their formulation is constrained by strict biocompatibility requirements and regulatory standards that govern material selection and performance. In practice, these materials must maintain adhesion, flexibility, and durability under sterilization, bodily fluids, and long-term exposure conditions. At the same time, they must not cause irritation, toxicity, or adverse biological responses, making formulation a balance between performance and biological safety.


Medical adhesive formulation today is constrained less by material choice and more by balancing biocompatibility, adhesion performance, moisture tolerance, wear duration, and atraumatic removal under strict regulatory limits. Even experienced formulators encounter systems that meet individual requirements but fail when these demands interact under real clinical use. 

This advanced training examines how medical adhesive and sealant systems behave under application and regulatory stress, focusing on silicone, acrylic, hydrogel, and bio-based chemistries used in long-wear pressure-sensitive applications, skin-contact devices, and internal or semi-invasive uses. The session highlights failure mechanisms linked to moisture exposure, skin variability, mechanical fatigue, and removal trauma, which are often missed during development. A strong emphasis is placed on biocompatibility as a design constraint, not a validation step. 

Participants will explore how ISO 10993 requirements, FDA expectations, and extractables and leachables considerations directly influence polymer selection, crosslink density, and additive strategy. The training focuses on decision frameworks that help advanced formulators design medical adhesives that remain stable, compliant, and clinically reliable over product lifetime.

Why Not To Miss This Training?

If you work with medical adhesives, this training gives you control earlier in the development cycle, when decisions still matter and failures are still preventable;

  1. Identify failure risks before they surface in validation or clinical use: Learn how to recognize formulation decisions that pass lab tests but fail during sterilization, wear, or regulatory review
  2. Preserve formulation freedom under regulatory constraints: Understand how ISO 10993, USP Class VI, and sterilization requirements shape material choices before options quietly disappear.
  3. Design adhesion that survives real skin conditions: Gain practical insight into managing hydration, motion, regeneration, and removal without increasing trauma or complaints.
  4. Make early polymer and crosslinking choices with long-term outcomes in mind: Avoid decisions that lock in future problems with tack, cohesion, removability, or biocompatibility.
  5. Reduce costly rework by learning from proven industry cases: Apply lessons from real medical adhesive failures to shorten development cycles and improve approval confidence.

Who Should Attend?

This industry-recommended training is essential for:

    • R&D Chemists, Formulators, Scientists: Enhance your formulations for medical applications.
    • Technical Service & Lab Managers: Improve adhesive performance and troubleshooting.
    • Product Managers & Developers: Stay updated on innovations and regulatory standards.
    • OEMs & Brand Owners: Gain insights into high-performance adhesive solutions.

Training Outline
  • Strategic Landscape of Medical Adhesives
  • Requirements & Standards for Medical Adhesives
    • ISO 10993, USP Class VI, FDA 21 CFR compliance
    • Biocompatibility & cytotoxicity essentials
    • Sterilization compatibility
    • Tack, peel, and shear performance on skin
  • Engineering Biointerface Adhesion
    • Adhesion under real skin conditions
    • Matching mechanical properties
    • Failure modes and prevention
    • Formulating for wear and comfort
  • Polymer Design & Crosslinking Chemistry
    • Medical-grade polymers and hybrids
    • Crosslinking methods for optimal performance
    • Tuning tack and cohesion
    • Rheology for stability and application
  • Application-Specific Formulation Strategies
    • Wearables: Long-term wear, comfort, sensor integration
    • Wound Care: Moisture management, easy removal
    • TDDS: Drug compatibility and diffusion control
    • Implantables: Biodegradability, in vivo curing
  • Managing Performance Trade-Offs
  • Future Risk & Innovation Pressure
  • Case Studies & Practical Lessons
  • Q&A session to clear doubts

Frequently Asked Questions
  1. What makes adhesives used in the medical industry different?
    They must meet strict biocompatibility and regulatory requirements while maintaining performance.
  2. What is biocompatibility in medical adhesives?
    It refers to the ability of a material to perform without causing harmful biological responses.
  3. Why are medical adhesives heavily regulated?
    Because they may come into direct or indirect contact with the human body.
  4. What factors affect adhesive performance in medical applications?
    Factors include sterilization conditions, exposure to bodily fluids, and long-term stability.
  5. What is the main challenge in formulating medical adhesives?
    The main challenge is balancing adhesion performance with biological safety and regulatory compliance.
  6. Why do medical adhesive failures have higher risk?
    Because failure can directly impact device function, patient safety, and regulatory approval.

Trainers List

Training Curriculum

Get Started Now!

Related Trainings